New Biological Links Between Autism and Alzheimer’s Challenges Decades of Brain Science Assumptions

New research suggests autism and Alzheimer’s may share biological origins, potentially changing how science treats brain health across the entire human lifespan.

By: AXL Media

Published: Apr 6, 2026, 8:09 AM EDT

Source: Information for this report was sourced from The Washington Post

Bridging the Gap Between Developmental and Degenerative Science

The long-standing divide in neuroscience between early-life neurodevelopment and late-life neurodegeneration is beginning to blur. For decades, autism and Alzheimer’s were treated as biologically unrelated, occupying opposite ends of the human lifespan. However, recent medical literature and genomic signals have forced experts to reconsider. Joseph Buxbaum, a prominent researcher initially skeptical of the link, is now among those exploring how the molecular foundations of autism might predispose the brain to the cognitive decline seen in Alzheimer’s. This shift in perspective suggests that the "wiring" of the brain in infancy and its "unraveling" in old age may be two sides of the same biological coin.

Shared Pathophysiological Markers and Protein Dynamics

A key area of inquiry focuses on the mechanics of cerebrospinal fluid (CSF) and the accumulation of neurotoxic proteins. Research published in Frontiers in Neuroscience indicates that both autism and Alzheimer’s exhibit disruptions in CSF drainage. In Alzheimer’s, this failure leads to the buildup of beta-amyloid and tau; in autism, similar obstructions may influence sensory processing and early development. Scientists are investigating whether the same "glymphatic" system failures that drive dementia are present, albeit in a different form, during the early stages of autism, potentially creating a lifelong vulnerability in the brain's waste-clearance systems.

Metabolic Overlap and Brain Glucose Hypometabolism

Beyond protein accumulation, the two conditions share significant metabolic signatures. Both show decreased whole-brain glucose metabolism, or "glucose hypometabolism," when viewed through advanced neuroimaging. In Alzheimer’s, this metabolic deficit often precedes clinical symptoms by years. Similarly, patients with autism display significant reductions in the brain's ability to utilize glucose, particularly in the left-brain regions. This shared inability to effectively power brain cells suggests that impaired energy transport may be a core driver for both developmental hurdles and later-life cognitive erosion.